Mapping large numbers of results may take a few moments.
Search Results
Showing 1 - 50 of 120 results found.
| Company | Activity | Company Description | Location | |
|---|---|---|---|---|
|
Company BD Technologies and Innovation (RTP) | Activity: Research and Development | Company Description BD is a global medical technology company working to improve medical discovery, diagnostics and the delivery of care. The RTP site, established in 1972, is the North American hub of BD's global enterprise R&D network. | Location Research Triangle Park |
|
Company Propella Therapeutics Inc. | Activity: Research and Development | Company Description Propella Therapeutics has developed a platform which combines lymphatic targeting with a medicinal chemistry optimization process to create therapeutics for cancer. The lead asset is PRL-02 (abiraterone decanoate) for prostate cancer. | Location Pittsboro |
 |
Company Accord Healthcare Inc. | Activity: Sales and Operations | Company Description Accord Healthcare is the marketing subsidiary of Intas Pharmaceuticals, an India-based company that focuses on manufacturing generic pharmaceuticals and biosimilars for the global market. | Location Durham |
| |
Company AccuGenomics Inc. | Activity: Production and Manufacturing | Company Description AccuGenomics manufactures custom gene expression tests to diagnose and monitor cancer treatment. Its technologies include Standard Nucleic Acid Quantification for RNA and DNA Sequencing for any NGS platform analysis. | Location Wilmington |
| |
Company AccuNovo Biotechnologies Inc. | Activity: Research and Development | Company Description Accunovo is developing novel targeted PET imaging probes through a combination of unique biomarker-binding molecules and imaging-guided precision radiopharmaceuticals for solid tumors. | Location Chapel Hill |
| |
Company Aktis Oncology | Activity: Research and Development | Company Description Aktis Oncology is developing targeted radiopharmaceuticals to treat solid tumor cancers. | Location Durham |
| |
Company Allucent (Cary) | Activity: Contract Research and Testing | Company Description Allucent provides contract research services, including preclinical & clinical study design & management, regulatory assessments, data management, clinical pharmacology modeling and simulation, medical writing & submission of regulatory documents. | Location Cary |
| |
Company AlphaVax Inc. | Activity: Research and Development | Company Description AlphaVax develops vaccine technology with applications in infectious disease, cancer and biodefense threats. | Location Research Triangle Park |
| |
Company Amgen Inc. | Activity: Production and Manufacturing | Company Description Amgen will manufacture therapeutics for cardiovascular disease, oncology, bone health, neuroscience, nephrology and inflammation. The site is expected to be operational by 2025. | Location Apex |
| |
Company AnelleO | Activity: Research and Development | Company Description AnelleO is developing a 3D-printed intravaginal ring that can be used for treating infertility and a wide range of other women's health conditions. | Location Chapel Hill |
| |
Company AntiXero LLC | Activity: Research and Development | Company Description AntiXero is developing a therapy for cancer-related dry mouth. | Location Raleigh |
| |
Company AstraZeneca (Durham-Winchester) | Activity: Research and Development | Company Description AstraZeneca's Winchester Place site in Durham specializes in research and development across the biopharmaceuticals, vaccines and immune therapies, rare disease and oncology business units. | Location Durham |
| |
Company Atrium Health Division of Therapeutic Research and Development | Activity: Research and Development | Company Description The Division of Therapeutic Research and Development at Atrium Health conducts clinical studies, patient-focused translational research and outcomes research. | Location Charlotte |
| |
Company Attagene Inc. | Activity: Contract Research and Testing | Company Description Attagene has developed a pathway profiling technology to evaluate the impact of pharmaceuticals, environmental chemicals and natural products on over 100 transcription factors and 48 nuclear receptors. | Location Morrisville |
| |
Company Avicenna Biosciences Inc. | Activity: Research and Development | Company Description Avicenna Biosciences is a drug development company using machine learning-enhanced medicinal chemistry to accelerate the lead-to-candidate optimization process for small molecule drug development. | Location Durham |
| |
Company Bantam Pharmaceutical LLC | Activity: Research and Development | Company Description Bantam Pharmaceutical develops small molecule cancer therapeutics for hematological malignancies and select solid tumors. | Location Durham |
| |
Company BD Diagnostics (Mebane) | Activity: Production and Manufacturing | Company Description BD Diagnostics develops and commercializes molecular diagnostic products for women's health and various cancers. | Location Mebane |
| |
Company Beam Therapeutics | Activity: Production and Manufacturing | Company Description Beam Therapeutics will manufacture precision genetic medicines through the use of base editing technology at its RTP site. | Location Durham |
| |
Company Benecyte Inc. | Activity: Production and Manufacturing | Company Description Benecyte develops and manufactures cell-based therapeutics designed to treat unmet medical needs including cancer, autoimmune and inflammatory diseases. | Location Durham |
| |
Company BioCytics Inc. | Activity: Research and Development | Company Description BioCytics researches and develops personalized cellular immunotherapy cancer therapies with the latest technology and equipment. BioCytics also offers contract R&D and is co-located with its sister company, the Carolina BioOncology Institute. | Location Huntersville |
| |
Company BioMedomics Inc. | Activity: Research and Development | Company Description BioMedomics develops and manufactures point-of-care (POC) diagnostics in hematology oncology, virology, women’s health and dermatology. | Location Morrisville |
| |
Company Blue Ridge Institute for Medical Research | Activity: Research and Development | Company Description Blue Ridge Institute for Medical Research (BRIMR) researches small-molecule inhibitors of protein kinases and targeted cancer therapies. BRIMR also generates an annual ranking of NIH funding for U.S. medical schools and their departments. | Location Hendersonville |
| |
Company Caidya | Activity: Contract Research and Testing | Company Description Caidya provides full global CRO service to pharmaceutical and biotechnology companies, working across all major therapeutic areas including oncology, gastroenterology and women's health and rare disease. | Location Morrisville |
| |
Company Cancer Advances Inc. | Activity: Research and Development | Company Description Cancer Advances, a subsidiary of Cato Bioventures, develops immunomodulator therapeutics to treat gastrointestinal cancers. | Location Durham |
| |
Company CARsgen Therapeutics | Activity: Production and Manufacturing | Company Description CARsgen Therapeutics develops innovative CAR-T cell therapies for the treatment of hematological malignancies and solid tumors. | Location Durham |
| |
Company Cellectis | Activity: Production and Manufacturing | Company Description Cellectis develops gene-editing technologies and cell therapies to treat cancers of the blood, myeloid, and lymphatic systems. The Raleigh location is the company's GMP manufacturing plant for Cellectis' portfolio of UCART drug products. | Location Raleigh |
| |
Company Cellective BioTherapy Inc. | Activity: Research and Development | Company Description Cellective BioTherapy is developing cellular and monoclonal antibody-based platforms for treating cancers, autoimmunity and immunodeficiency through the manipulation of B cells and their functional subsets. | Location Chapel Hill |
| |
Company CellSolutions LLC | Activity: Research and Development | Company Description CellSolutions develops liquid-based preparation and evaluation systems for cytology applications. The company's primary area of focus is women's health, including cervical cancer screening, precancer detection and evaluation of infectious disease. | Location Greensboro |
| |
Company Centaur Bio Inc. | Activity: Research and Development | Company Description Centaur Bio develops technology that facilitates precision drug delivery, which will potentially improve treatments for solid tumors and CNS disorders. | Location Charlotte |
| |
Company Charles River Laboratories (Durham) | Activity: Contract Research and Testing | Company Description Charles River Laboratories' Oncology Center of Excellence provides in vivo and in vitro oncology and immuno-oncology research services. | Location Durham |
| |
Company ChemQ Bioscience LLC | Activity: Production and Manufacturing | Company Description ChemQ Bioscience develops and markets novel liquid products, such as bio-preservation media, tissue perfusion solutions and liquid-based cytology processing kits. ChemQ also offers contract research services and custom formulation. | Location Research Triangle Park |
| |
Company CivaTech Oncology Inc. | Activity: Research and Development | Company Description CivaTech Oncology has developed targeted implantable radiation devices to treat many cancer types. Products provide a targeted, customized radiation dose during a surgical resection procedure or in outpatient therapies to treat cancers. | Location Morrisville |
| |
Company Claradele Pharmaceuticals Inc. | Activity: Research and Development | Company Description Claradele Pharmaceuticals is developing an immunotherapy product to treat melanoma. | Location Winterville |
| |
Company Cloud Pharmaceuticals Inc. | Activity: Contract Research and Testing | Company Description Cloud Pharmaceuticals designs and develops novel drug molecules using computational design for a wide range of therapeutic areas including cancer, inflammation, CNS disorders and rare diseases. | Location Research Triangle Park |
| |
Company Data Driven Bioscience Inc. | Activity: Research and Development | Company Description Data Driven Bioscience uses genomic tests, datasets and machine learning solutions to enable hospitals and pharmaceutical companies to diagnose cancer and personalize cancer treatment. | Location Durham |
| |
Company Datar Cancer Genetics | Activity: Research and Development | Company Description Datar Cancer Genetics develops blood-based diagnostics for early cancer detection and identifies personalized treatment strategies based on genomic and cellular analysis of a patient's cancer. | Location Morrisville |
| |
Company Deep Creek Pharma LLC | Activity: Research and Development | Company Description DeepCreek Pharma is commercializing CF10 fluoropyrimidine polymer technology to treat colon cancer. | Location Yadkinville |
| |
Company DelAQUA Pharmaceuticals Inc. | Activity: Research and Development | Company Description DelAQUA Pharmaceuticals is developing technology to enhance the solubility and stability of drugs and drug candidates and to improve their efficacy and safety. | Location Chapel Hill |
| |
Company DotBio LLC | Activity: Research and Development | Company Description DotBio develops immuno-oncology therapies. | Location Weddington |
| |
Company Eisai Inc. | Activity: Sales and Operations | Company Description Eisai discovers, develops and markets pharmaceuticals in neurology and oncology-critical care. This site supports global partnerships, quality assurance and supply chain for the company. | Location Raleigh |
| |
Company Enfuego Therapeutics Inc. | Activity: Research and Development | Company Description Enfuego Therapeutics is developing novel RNA interference-(RNAi)-based and antisense oligo therapeutics. | Location Morrisville |
| |
Company ENVIGEN Pharmaceuticals Inc. | Activity: Research and Development | Company Description ENVIGEN develops classes of small drug-like molecules to treat life-threatening diseases including cancer, HIV/AIDS and neurological disorders. | Location Durham |
| |
Company ER Therapeutics LLC | Activity: Research and Development | Company Description ER Therapeutics is developing and commercializing therapeutics for cancer. | Location Chapel Hill |
| |
Company EydisBio Inc. | Activity: Research and Development | Company Description Eydis Bio is developing a platform of small molecule therapeutics targeting a variety of diseases driven by aberrant inflammatory/autoimmune processes. | Location Durham |
| |
Company FastBack Bio LLC | Activity: Research and Development | Company Description FastBack Bio is developing CAR-T therapy for treatment of solid tumors. | Location Raleigh |
| |
Company Fennec Pharmaceuticals Inc. | Activity: Research and Development | Company Description Fennec Pharmaceuticals develops a sodium thiosulfate formula for the prevention of ototoxicity from cisplatin in pediatric patients. | Location Research Triangle Park |
| |
Company FLAG Therapeutics Inc. | Activity: Research and Development | Company Description FLAG Therapeutics develops cancer therapeutics using new classes of small molecules which have selective dual activity: antiangiogenesis and chemotherapeutic. | Location Raleigh |
| |
Company Focal Medical Inc. | Activity: Research and Development | Company Description Focal Medical develops novel therapeutic products based on its local drug delivery technology platform. | Location Cary |
| |
Company Foundation Medicine Inc. | Activity: Research and Development | Company Description Foundation Medicine develops and provides clinical assays that provide a comprehensive genomic profile to identify molecular alterations in a patient's cancer and match them with targeted therapies and clinical trials. | Location Morrisville |
| |
Company G1 Therapeutics Inc. | Activity: Research and Development | Company Description G1 Therapeutics is a commercial-stage biopharmaceutical company focused on the discovery, development and commercialization of innovative therapies for those affected by cancer. | Location Research Triangle Park |